Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,485.60
+8.35 (0.57%)
At close: Jan 22, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 376.9 billion as of January 23, 2026. Its market cap has decreased by -14.37% in one year.
Market Cap
376.90B
Enterprise Value
391.53B
Revenue
93.59B
Ranking
n/a
PE Ratio
45.32
Stock Price
1,485.60
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 376.90B, an increase of 11,609.61%. That is a compound annual growth rate of 22.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 376.90B | 4.70% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.36T |
| Dr. Reddy's Laboratories | 1.01T |
| Lupin | 988.99B |
| Abbott India | 588.57B |
| GlaxoSmithKline Pharmaceuticals | 403.16B |
| J. B. Chemicals & Pharmaceuticals | 297.75B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |